Sponsorship: British Embassy
Support: JSGT, BSGT, ISCGT, JMU 21st Century COE Program
Date: Thursday 12th October 2006
Venue: British Embassy New Hall

08:30 − Registration

09:00 − Welcome Greetings --- Edward Wright
09:05 − Opening Remarks --- Keiya Ozawa
09:10 − Introduction of UK Speakers --- Matthew J.A. Wood
09:15 − Introduction of Japanese Speakers --- Keiya Ozawa

Chairperson: Takashi Shimada
09:20 − 09:40 Adrian Thrasher, Institute of Child Health, London
　　　“Gene therapy strategies for immunodeficiency”
09:40 − 10:00 Masafumi Onodera, University of Tsukuba
　　　“Current situation of stem cell gene therapy in Japan”
10:00 − 10:20 M. Yvonne Alexander, University of Manchester
　　　“Molecular and cellular strategies to prevent atherosclerotic plaque development”

Chairperson: Matthew J.A. Wood
10:35 − 10:55 Keiya Ozawa, Jichi Medical University
　　　“Applications of AAV to gene therapy”
10:55 − 11:15 Andrew H. Baker, University of Glasgow
　　　“Viral vector design for targeted in vivo gene delivery”
11:15 − 11:35 Takashi Shimada, Nippon Medical School
　　　“Gene therapy of lysosomal storage disorders with neurological lesions”
11:35 − 11:55 Leonard W. Seymour, University of Oxford
　　　“Systemic delivery of oncolytic adenoviruses”

Chairperson: Keiya Ozawa
13:00 − 13:20 Kohnosuke Mitani, Research Center for Genomic Medicine, Saitama Medical School
　　　“Gene targeting with viral vectors for gene therapy and stem cell research”
13:20 − 13:40 James Birchall, Cardiff University
　　　“Microneedles for cutaneous cell and gene therapy”
13:40 − 14:00 Makoto Inoue, DNAVEC Corporation
　　　“Technology and application on a new class cytoplasmic RNA vector, Sendai virus vector”
14:00 − 14:20 Norman J. Maitland, University of York
　　　“Cancer stem cells: are they the basis of tumour recurrence after treatment for prostate cancer?”

Chairperson: Leonard W. Seymour
14:30 − 14:50 Yasufumi Kaneda, Osaka University
　　　“Development of cancer treatment strategies based on HVJ envelope vector system”
14:50 − 15:10 Andrew D. Miller, Imperial College London
　　　“Synthetic, self assembly ABCD nanoparticles; nanomedicine solutions for gene therapy applications?
15:10 − 15:30 Makiya Nishikawa, Kyoto University
　　　“Efficient delivery of therapeutic genes and short hairpin RNA by intravascular injection of naked plasmid DNA”
15:30 − 15:50 Matthew J.A. Wood, University of Oxford
　　　“Nucleic acid therapies for neuromuscular disease”

16:00 − Registration for Open Session
16:30 − 18:00 Open Session “Towards UK-Japan Gene Therapy Collaboration”
16:30 − 16:35 Opening Remarks --- Edward Wright

Chairpersons: Matthew J.A. Wood & Keiya Ozawa
16:35 − 16:55 Keynote Speech on Gene Therapy in the UK
　　　(I) 16:35 − 16:45 Leonard W. Seymour, University of Oxford
　　　(II) 16:45 − 16:55 Adrian Thrasher, Institute of Child Health, London
16:55 − 17:15 Keynote Speech on Gene Therapy in Japan
16:55 − 17:05 Takashi Shimada, Nippon Medical School
　　　“Focusing on viral vector mediated gene therapy”
17:05 − 17:15 Yasufumi Kaneda, Osaka University
　　　“Development of non-viral vectors in Japan”
17:15 − 17:30 Summary of Closed Session
　　　UK side --- Matthew J.A. Wood, University of Oxford
　　　Japan side --- Keiya Ozawa, Jichi Medical University
17:30 − 17:50 Q & A and General Discussion
17:50 − 17:55 Conclusions --- Keiya Ozawa
17:55 − 18:00 Closing Remarks --- Edward Wright
18:00 − 19:30 Reception

The 2nd UK-Japan GT Workshop 2006プログラム(PDF 252KB)

UK-Japan Gene Therapy Workshop / ISCGT
(International Society for Cell and Gene Therapy of Cancer)
Joint Session
"Cancer Gene Therapy from Bench to Clinic"
Programme

Date: Saturday 14th October 2006
Time: 08:30-12:00
Venue: Makuhari-Messe International Conference Hall

Chairs: Len Seymour, University of Oxford
Keiya Ozawa, Jichi Medical University

Presentation time for speakers: 18min
15 min presentation with 3 min discussion

JS-1 Len Seymour, University of Oxford
　　　Systemic delivery of oncolytic adenoviruses

JS-2 Tomoki Todo, University of Tokyo
　　　Oncolytic virus therapy using genetically engineered herpes simplex Viruses

JS-3 Andrew Baker, University of Glasgow
　　　Viral vector design for targeted in vivo gene delivery

JS-4 Hirofumi Hamada, Sapporo Medical University
　　　Antibody-targeted selective gene delivery through FZ33 fiber-modified adenoviral vectors

JS-5 James Birchall, Cardiff University
　　　Microneedles for cutaneous cell and gene therapy

JS-6 Kazuyuki Matsushita, Chiba University
　　　Transcriptional c-myc suppressor FUSE-binding protein (FBP)-interacting repressor for cancer gene therapy

JS-7 Norman Maitland, York University
　　　Cancer Stem Cells: are they the basis of tumour recurrence after treatment for prostate cancer?

JS-8 Takashi Okada, Jichi Medical University
　　　Vector-producing tumor-tracking stem cells for suicide cancer gene therapy

JS-9 Andrew Miller, Imperial College London
　　　Synthetic, self assembly ABCD nanoparticles; nanomedicine solutions for gene therapy applications?

JS-10 Jun Yoshida, Nagoya University
　　　Design/development and manufacture of processed cells and non-viral vector for clinical research